269 related articles for article (PubMed ID: 25805751)
1. Proton-Pump Inhibitor Exposure Aggravates Clostridium difficile-Associated Colitis: Evidence From a Mouse Model.
Hung YP; Ko WC; Chou PH; Chen YH; Lin HJ; Liu YH; Tsai HW; Lee JC; Tsai PJ
J Infect Dis; 2015 Aug; 212(4):654-63. PubMed ID: 25805751
[TBL] [Abstract][Full Text] [Related]
2. Complicated Clostridium difficile colitis in children with cystic fibrosis: association with gastric acid suppression?
Com G; Cetin N; O'Brien CE
J Cyst Fibros; 2014 Jan; 13(1):37-42. PubMed ID: 23993432
[TBL] [Abstract][Full Text] [Related]
3. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
Aseeri M; Schroeder T; Kramer J; Zackula R
Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
[TBL] [Abstract][Full Text] [Related]
4. The Proton Pump Inhibitor Omeprazole Does Not Promote Clostridioides difficile Colonization in a Murine Model.
Tomkovich S; Lesniak NA; Li Y; Bishop L; Fitzgerald MJ; Schloss PD
mSphere; 2019 Nov; 4(6):. PubMed ID: 31748246
[TBL] [Abstract][Full Text] [Related]
5. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.
Barletta JF; El-Ibiary SY; Davis LE; Nguyen B; Raney CR
Mayo Clin Proc; 2013 Oct; 88(10):1085-90. PubMed ID: 24012413
[TBL] [Abstract][Full Text] [Related]
6. Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure.
Stevens V; Dumyati G; Brown J; Wijngaarden E
Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1035-42. PubMed ID: 21833992
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors and risk of Clostridium difficile infection: association or causation?
Villafuerte-Gálvez JA; Kelly CP
Curr Opin Gastroenterol; 2018 Jan; 34(1):11-18. PubMed ID: 29095766
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection.
Turco R; Martinelli M; Miele E; Roscetto E; Del Pezzo M; Greco L; Staiano A
Aliment Pharmacol Ther; 2010 Apr; 31(7):754-9. PubMed ID: 20047577
[TBL] [Abstract][Full Text] [Related]
9. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.
Kwok CS; Arthur AK; Anibueze CI; Singh S; Cavallazzi R; Loke YK
Am J Gastroenterol; 2012 Jul; 107(7):1011-9. PubMed ID: 22525304
[TBL] [Abstract][Full Text] [Related]
10. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
Gordon D; Young LR; Reddy S; Bergman C; Young JD
J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
[TBL] [Abstract][Full Text] [Related]
11. Clostridium difficile colitis: wash your hands before stopping the proton pump inhibitor.
Metz DC
Am J Gastroenterol; 2008 Sep; 103(9):2314-6. PubMed ID: 18924259
[TBL] [Abstract][Full Text] [Related]
12. Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis.
Cadle RM; Mansouri MD; Logan N; Kudva DR; Musher DM
Am J Health Syst Pharm; 2007 Nov; 64(22):2359-63. PubMed ID: 17989446
[TBL] [Abstract][Full Text] [Related]
13. How much do PPIs contribute to C. difficile infections?
Leontiadis GI; Miller MA; Howden CW
Am J Gastroenterol; 2012 Jul; 107(7):1020-1. PubMed ID: 22764024
[TBL] [Abstract][Full Text] [Related]
14. Comparative role of antibiotic and proton pump inhibitor in experimental Clostridium difficile infection in mice.
Kaur S; Vaishnavi C; Prasad KK; Ray P; Kochhar R
Microbiol Immunol; 2007; 51(12):1209-14. PubMed ID: 18094539
[TBL] [Abstract][Full Text] [Related]
15. Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficile Infection.
McDonald EG; Milligan J; Frenette C; Lee TC
JAMA Intern Med; 2015 May; 175(5):784-91. PubMed ID: 25730198
[TBL] [Abstract][Full Text] [Related]
16. Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis.
Oshima T; Wu L; Li M; Fukui H; Watari J; Miwa H
J Gastroenterol; 2018 Jan; 53(1):84-94. PubMed ID: 28744822
[TBL] [Abstract][Full Text] [Related]
17. Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis.
Tariq R; Singh S; Gupta A; Pardi DS; Khanna S
JAMA Intern Med; 2017 Jun; 177(6):784-791. PubMed ID: 28346595
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients.
Barletta JF; Sclar DA
Crit Care; 2014 Dec; 18(6):714. PubMed ID: 25540023
[TBL] [Abstract][Full Text] [Related]
19. Risk and Severity of Hospital-Acquired Clostridium difficile Infection in Patients Taking Proton Pump Inhibitors.
Lewis PO; Litchfield JM; Tharp JL; Garcia RM; Pourmorteza M; Reddy CM
Pharmacotherapy; 2016 Sep; 36(9):986-93. PubMed ID: 27455386
[TBL] [Abstract][Full Text] [Related]
20. Does PPI therapy predispose to Clostridium difficile infection?
Pant C; Madonia P; Minocha A
Nat Rev Gastroenterol Hepatol; 2009 Sep; 6(9):555-7. PubMed ID: 19713988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
